We are live on ! Find out more
SCA

Stonebridge Capital Advisors Portfolio holdings

AUM $1.43B
1-Year Est. Return 21.98%
This Fund
S&P 500
This Quarter Est. Return
+7.24%
1 Year Est. Return
+21.98%
3 Year Est. Return
+64.22%
5 Year Est. Return
+80.67%
10 Year Est. Return
+293.7%
AUM
$437M
AUM Growth
+$30.2M
Cap. Flow
+$3.43M
Cap. Flow %
0.78%
Top 10 Hldgs %
24.44%
Holding
187
New
7
Increased
67
Reduced
70
Closed
10

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$4.88M
2
IBM icon
IBM
IBM
+$2.54M
3
GE icon
GE Aerospace
GE
+$1.57M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$846K
5
UNH icon
UnitedHealth
UNH
+$594K

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$2.28M
2
NVS icon
Novartis
NVS
+$2.2M
3
BA icon
Boeing
BA
+$1.69M
4
PFE icon
Pfizer
PFE
+$1.27M
5
AAPL icon
Apple
AAPL
+$529K

Sector Composition

Rank Sector Weight
1 Financials 15.2%
2 Technology 13.51%
3 Healthcare 13.47%
4 Consumer Discretionary 11.17%
5 Industrials 10.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HAS icon
101
Hasbro
HAS
$12.6B
$837K 0.19%
9,207
+949
+11% +$89K
PFE icon
102
Pfizer
PFE
$140B
$821K 0.19%
23,887
-37,242
-61% -$1.27M
GSK icon
103
GSK
GSK
$103B
$800K 0.18%
18,052
+458
+3% +$21.2K
BAC icon
104
Bank of America
BAC
$435B
$749K 0.17%
25,386
+847
+3% +$23.3K
GIS icon
105
General Mills
GIS
$19.2B
$721K 0.17%
12,150
+100
+0.8% +$5.41K
ACN icon
106
Accenture
ACN
$89.9B
$693K 0.16%
4,530
-486
-10% -$70.4K
LNT icon
107
Alliant Energy
LNT
$19.4B
$681K 0.16%
15,980
XEL icon
108
Xcel Energy
XEL
$51B
$676K 0.15%
14,044
+476
+4% +$23.6K
MMP
109
DELISTED
Magellan Midstream Partners, L.P.
MMP
$638K 0.15%
8,992
ECL icon
110
Ecolab
ECL
$75.6B
$609K 0.14%
4,536
+200
+5% +$26.6K
AMLP icon
111
Alerian MLP ETF
AMLP
$12.9B
$555K 0.13%
10,280
+2,095
+26% +$112K
DRI icon
112
Darden Restaurants
DRI
$22.5B
$535K 0.12%
5,573
-300
-5% -$25.3K
KMB icon
113
Kimberly-Clark
KMB
$36.4B
$534K 0.12%
4,427
+150
+4% +$17.5K
TWTR
114
DELISTED
Twitter, Inc.
TWTR
$528K 0.12%
22,001
-1,200
-5% -$24.6K
PM icon
115
Philip Morris
PM
$301B
$464K 0.11%
4,390
-80
-2% -$8.53K
SPY icon
116
State Street SPDR S&P 500 ETF Trust
SPY
$781B
$460K 0.11%
1,725
+181
+12% +$47.1K
WY icon
117
Weyerhaeuser
WY
$17.3B
$441K 0.1%
12,520
BWLD
118
DELISTED
Buffalo Wild Wings, Inc.
BWLD
$436K 0.1%
2,790
-55
-2% -$7.24K
OSBC icon
119
Old Second Bancorp
OSBC
$1.24B
$413K 0.09%
30,232
-3,000
-9% -$39.8K
TSM icon
120
TSMC
TSM
$2.09T
$413K 0.09%
10,422
-1,800
-15% -$72.9K
MO icon
121
Altria Group
MO
$122B
$411K 0.09%
5,755
+515
+10% +$34.5K
MA icon
122
Mastercard
MA
$477B
$399K 0.09%
2,635
+140
+6% +$20.8K
EW icon
123
Edwards Lifesciences
EW
$47.6B
$383K 0.09%
10,200
-180
-2% -$6.61K
WWD icon
124
Woodward
WWD
$25B
$375K 0.09%
4,900
-600
-11% -$46.8K
LUV icon
125
Southwest Airlines
LUV
$22.1B
$365K 0.08%
5,579
-777
-12% -$45.7K

Similar funds

Stonebridge Capital Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Stonebridge Capital Advisors held 187 positions worth $437M, up 7.4% from $407M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Stonebridge Capital Advisors's Q4 2017 filing shows 7 new, 67 increased, 70 reduced and 10 closed positions. Its largest new stake was Caterpillar: 1,734 shares worth $273K. The largest sale was AbbVie, an estimated $2.28M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.

  • Stonebridge Capital Advisors's largest Q4 2017 buy was Caterpillar: 1,734 shares worth $273K.
  • Stonebridge Capital Advisors added most to Medtronic in Q4 2017, an estimated $4.88M increase.
  • Stonebridge Capital Advisors's biggest Q4 2017 reduction was AbbVie, cutting an estimated $2.28M.
  • Stonebridge Capital Advisors fully exited Novartis in Q4 2017, selling an estimated $2.2M.
  • Stonebridge Capital Advisors's ten largest holdings make up 24% of its $437M portfolio in Q4 2017.
  • Stonebridge Capital Advisors opened 7 new positions and closed 10 in Q4 2017.
  • Stonebridge Capital Advisors's portfolio value rose 7.4% quarter-over-quarter to $437M.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2017, filed 15 Feb 2018.